Indeed, it is known that genetic ablation of MCSF-1 in CRC cells reduces the influx of immunosuppressive MCSF-1R-expressing TAMs within tumors thus resulting in an increase of Foxp3+ regulatory T cells that limit the attack of CD8+ T cells on tumors (66). The gene discussed is CD8A; the disease is colorectal carcinoma.